192 related articles for article (PubMed ID: 12801603)
21. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
22. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lu Z; Zhang X; Li Y; Jin J; Huang Y
J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
[TBL] [Abstract][Full Text] [Related]
23. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice.
Zhou J; Møller J; Ritskes-Hoitinga M; Larsen ML; Austin RC; Falk E
Atherosclerosis; 2003 Jun; 168(2):255-62. PubMed ID: 12801608
[TBL] [Abstract][Full Text] [Related]
24. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
[TBL] [Abstract][Full Text] [Related]
25. alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet.
Yi X; Maeda N
Diabetes; 2006 Aug; 55(8):2238-44. PubMed ID: 16873686
[TBL] [Abstract][Full Text] [Related]
26. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
27. Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.
Iwasa S; Fan J; Miyauchi T; Watanabe T
Pathobiology; 2001; 69(1):1-10. PubMed ID: 11641611
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes.
Lyngdorf LG; Gregersen S; Daugherty A; Falk E
Cardiovasc Res; 2003 Oct; 59(4):854-62. PubMed ID: 14553825
[TBL] [Abstract][Full Text] [Related]
30. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
[TBL] [Abstract][Full Text] [Related]
31. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
[TBL] [Abstract][Full Text] [Related]
32. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
33. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
Bucciarelli LG; Wendt T; Qu W; Lu Y; Lalla E; Rong LL; Goova MT; Moser B; Kislinger T; Lee DC; Kashyap Y; Stern DM; Schmidt AM
Circulation; 2002 Nov; 106(22):2827-35. PubMed ID: 12451010
[TBL] [Abstract][Full Text] [Related]
34. Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice.
Guo Z; Mitchell-Raymundo F; Yang H; Ikeno Y; Nelson J; Diaz V; Richardson A; Reddick R
Mech Ageing Dev; 2002 Apr; 123(8):1121-31. PubMed ID: 12044962
[TBL] [Abstract][Full Text] [Related]
35. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice.
Whitman SC; Ravisankar P; Daugherty A
J Interferon Cytokine Res; 2002 Jun; 22(6):661-70. PubMed ID: 12162876
[TBL] [Abstract][Full Text] [Related]
36. High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice.
Ketonen J; Merasto S; Paakkari I; Mervaala EM
Blood Press; 2005; 14(6):373-82. PubMed ID: 16403692
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
38. Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
George J; Afek A; Keren P; Herz I; Goldberg I; Haklai R; Kloog Y; Keren G
Circulation; 2002 May; 105(20):2416-22. PubMed ID: 12021230
[TBL] [Abstract][Full Text] [Related]
39. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic Acid.
Nakata Y; Maeda N
Circulation; 2002 Mar; 105(12):1485-90. PubMed ID: 11914259
[TBL] [Abstract][Full Text] [Related]
40. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation.
Harja E; Bucciarelli LG; Lu Y; Stern DM; Zou YS; Schmidt AM; Yan SF
Circ Res; 2004 Feb; 94(3):333-9. PubMed ID: 14670837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
